SPRAVATO®
SPRAVATO® (esketamine) CIII nasal spray is the first prescription nasal spray, taken with an oral antidepressant, for:
Adults with treatment-resistant depression
Depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions
Our psychiatric nurse practitioners are available to guide patients dealing with Treatment-Resistant Depression about the use of Spravato (Esketamine) and other treatment options.
English